The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Paul Steven M since year 2005.
The trader's CIK number is 1237564.
At the time of the last reporting, Paul Steven M was the President & CEO of Karuna Therapeutics, Inc. .
(stock ticker symbol KRTX).
See this page for all insider trading activities at Karuna Therapeutics, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-06-28 | KRTX | Karuna Therapeutics, Inc. | Buy | 10,000 | 23.14 | 231,450 |
| 2019-03-21 | SAGE | Sage Therapeutics, Inc. | Sale | 7,879 | 161.04 | 1,268,810 |
| 2019-03-18 | SAGE | Sage Therapeutics, Inc. | Sale | 3,775 | 161.04 | 607,944 |
| 2019-03-20 | SAGE | Sage Therapeutics, Inc. | Sale | 56,646 | 161.30 | 9,136,829 |
| 2019-02-25 | SAGE | Sage Therapeutics, Inc. | Sale | 2,000 | 161.00 | 322,000 |
| 2019-02-15 | SAGE | Sage Therapeutics, Inc. | Sale | 49,461 | 161.02 | 7,964,210 |
| 2019-02-19 | SAGE | Sage Therapeutics, Inc. | Sale | 1,543 | 161.75 | 249,578 |
| 2018-03-06 | SAGE | Sage Therapeutics, Inc. | Sale | 58,139 | 172.00 | 9,999,908 |
| 2016-01-14 | VYGR | Voyager Therapeutics, Inc. | Buy | 10,000 | 14.07 | 140,690 |
| 2015-09-01 | SAGE | Sage Therapeutics, Inc. | Sale | 20,000 | 52.40 | 1,047,900 |
| 2015-08-03 | SAGE | Sage Therapeutics, Inc. | Sale | 20,000 | 67.15 | 1,343,000 |
| 2015-07-01 | SAGE | Sage Therapeutics, Inc. | Sale | 20,000 | 69.81 | 1,396,300 |
| 2015-06-01 | SAGE | Sage Therapeutics, Inc. | Sale | 20,000 | 72.65 | 1,453,020 |
| 2015-05-01 | BFAM | Sage Therapeutics, Inc. | Sale | 20,000 | 53.31 | 1,066,200 |
| 2015-04-01 | SAGE | Sage Therapeutics, Inc. | Sale | 20,000 | 48.51 | 970,200 |
| 2015-01-26 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 1,000 | 95.00 | 95,000 |
| 2015-01-02 | SIAL | Sigma Aldrich Corp | Option Ex | 684 | .00 | 0 |
| 2014-07-23 | SAGE | Sage Therapeutics, Inc. | Buy | 10,000 | 18.00 | 180,000 |
| 2014-01-02 | SIAL | Sigma Aldrich Corp | Option Ex | 373 | .00 | 0 |
| 2010-02-01 | LLY | Lilly Eli & Co | Option Ex | 51,249 | .00 | 0 |
| 2008-02-04 | LLY | Lilly Eli & Co | Sale | 19,822 | 51.58 | 1,022,458 |
| 2007-05-21 | LLY | Lilly Eli & Co | Option Ex | 98,008 | 54.80 | 5,370,838 |
| 2007-05-15 | LLY | Lilly Eli & Co | Option Ex | 1,992 | 54.80 | 109,161 |
| 2007-03-12 | LLY | Lilly Eli & Co | Sale | 7,289 | 52.39 | 381,870 |
| 2007-02-12 | LLY | Lilly Eli & Co | Sale | 7,290 | 54.38 | 396,430 |
| 2007-02-08 | LLY | Lilly Eli & Co | Sale | 10,092 | 54.33 | 548,247 |
| 2006-10-20 | LLY | Lilly Eli & Co | Sale | 4,836 | 56.91 | 275,216 |
| 2006-09-15 | LLY | Lilly Eli & Co | Option Ex | 2,890 | 34.59 | 99,979 |
| 2006-04-21 | LLY | Lilly Eli & Co | Sale | 25,000 | 52.80 | 1,320,000 |
| 2006-02-02 | LLY | Lilly Eli & Co | Sale | 6,201 | 57.00 | 353,457 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Paul Steven M (President & CEO of Karuna Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.